[ Price : $8.95]
FDA clears an NEC Display Solutions of America 510(k) for its 21.3-inch MultiSync MD211G3 medical diagnostic display.[ Price : $8.95]
Eli Lilly says that its REGARD Phase 3 trial involving IMC-1121B (ramucirumab) in patients with metastatic gastric cancer met its ...[ Price : $8.95]
FDA reviewers say that Aegerion Pharmaceuticals lomitapide mesylate capsules reduced low-density lipoprotein cholesterol by 40%, b...[ Price : $8.95]
A Tufts analysis finds that in the past nine years, FDA has not issued a single Warning or untitled letter under Sec. 114 authorit...[ Price : $8.95]
FDA says its ongoing investigation of New England Compounding Center has raised the possibility of a a patient with possible menin...[ Price : $8.95]
Merck reports that results from a Phase 2 trial for odanacatib showed significantly increased bone mineral density (BMD) over a tw...[ Price : $8.95]
FDA Webview editor Jim Dickinson says the accelerating meningitis outbreak from New England Compounding Center reveals FDAs own ac...[ Price : $8.95]
FDA accepts for review a Delcath Systems NDA for its proprietary chemosaturation system with melphalan hydrochloride for injection...